Bone Physiology Flashcards
Alkaline Phosphate
ALP Marker of bone formation Activated by OSTEOBLASTS Made in Liver and bone elevated in Pagets, hyperpartathyroidism etc also measured in osteoporosis high in children
Osteocalcin
Specific marker for bone formation, released by osteoblasts
high in children
low in osteomalacia and rickets
Procollagen peptiedes (OINP
Marker of bone formation, correlate with increased bone density
Urinary hydroxyproline
marker of bone resorption
from collagen degradation
NTX or CTX
marker of bone resorption
Primary osteoporosis
increased bone fragility conferring risk of fx
Found in older men and women, not secondary to any other cause
Secondary osteoporosis
increased bone fragility conferring risk of fx
secondary to other causes of osteoporosis such as GC exs
Tx for osteoporosis
antiresorbtives such bisphosphonates
anabolics such as intermittent PTH injections
Osteomalacia
(Rickets=pediatric)
disorders in mineralization of the organic matrix
associated with decreased Vit D an low Pi
decreased bonde density, increased fx risk, and bowing of long bones
Paget’s Disease
Excessive osteoblast activity and hyperactive bone remodeling
can be asymptomatic until X ray, elevated ALP
can cause bone pain, deformity, fx
enlarged bones can cause tingling due to pinched nerves
tx=bisphosphinates–>decrease bone resorption–>because things are coupled would decrease bone formation
(there is currently no drug that directly inhibits bone formation)
Osteogenesis imperfecta
brittle bone diseases that occur due to mutations in collagen
lead to bone fx and deformity, wide range of severity, especially in wormian bones
OI type I
AD disease with decreased collagen PRODUCTION
delayed fontanelle closure, bone fragility. short stature, blue scerae, joint laxity, hearing loss
improves into adolescence
osteopenia and fx common
OI type II
EXTREME bone fragility
causes infantile death secondary to respiratory problems
Osteopetrosis
marble bone disease due to decreases osteoclast activity–>disorganized bone structure
increased fx risk
bisphosphonates
inhibits osteoclast activity, decreases bone resorption,